Rifaximin Versus Lactulose in Renal Failure

NCT00748904 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Liver Cirrhosis
Renal Failure

Interventions

DRUG: Rifaximin
DRUG: Lactulose

Sponsor

Weill Medical College of Cornell University